The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for ...

Health officials on Friday issued a fresh plea for Londoners to get vaccinated ahead of an expected surge of flu, Covid and ...

A new study shows otherwise healthy adults who take broad-spectrum antibiotics to treat community-acquired pneumonia are more likely to suffer adverse drug events. Also in the news: evolution of covid ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

The Centers for Disease Control and Prevention and the New Orleans Health Department encourage residents to vaccine against ...

To increase access to vaccinations, the Boston Public Health Commission in partnership with the City of Boston and Boston Centers for Youth and Families (BCYF) are hosting several free flu and ...

Sanofi's Q3 earnings surged, with a 14.4% increase in income to €4.61 billion, led by Dupixent and new launches. Revenue beat ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Sanofi reported third-quarter earnings and sales that beat analysts' expectations, boosted by earlier-than-anticipated deliveries of flu and respiratory syncytial virus vaccines and growing demand for ...

GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by ...

The Centers for Disease Control and Prevention is urging some people to get additional doses of the COVID-19 vaccine for ...

Arexvy is currently approved for active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older, and those 50 to 59 years of age who are at increased risk for ...